| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/14/1997 | US5593672 Inhaling zinc oxide |
| 01/14/1997 | US5593671 Method of attenuating lung capillary leak in a mammal |
| 01/14/1997 | US5593669 Pesticide, insecticide |
| 01/14/1997 | US5593667 Recombinant immune interferon having an intact carboxyl terminus |
| 01/14/1997 | US5593666 Methods and compositions for treating thrombocytopenia |
| 01/14/1997 | US5593665 Pharmaceutical compositions |
| 01/14/1997 | US5593622 Preparation of liposomes with peg-bound phospholipid on surface |
| 01/14/1997 | CA2088671C Use of canps-inhibitors in pharmaceutical preparations |
| 01/14/1997 | CA2053880C Treatment of motility disorders with a gnrh analog |
| 01/14/1997 | CA2046930C Stabilisation of k1k2p pro |
| 01/14/1997 | CA2046929C T-pa pro stabilisation |
| 01/14/1997 | CA2046598C T-pa solubilisation |
| 01/14/1997 | CA2020062C Antibiotic agent |
| 01/14/1997 | CA1338849C Lectins and antiretroviral drugs containing the lectins as active ingredient |
| 01/14/1997 | CA1338848C Hydrogenated derivatives of antibiotic a/16686 |
| 01/13/1997 | CA2180689A1 Use of lactoferrin for therapy of acute or recurrent infectious diseases by streptococcus pyogenes or other intracellular gram positive pathogen bacteria |
| 01/13/1997 | CA2180683A1 Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases |
| 01/13/1997 | CA2180215A1 Medicament for nasal administration |
| 01/09/1997 | WO1997000963A1 Diagnostic test for equine arteritis virus mediated disease |
| 01/09/1997 | WO1997000960A1 Novel human chemotactic cytokine |
| 01/09/1997 | WO1997000959A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 01/09/1997 | WO1997000958A1 NOVEL TGF-β LIKE CYTOKINE |
| 01/09/1997 | WO1997000957A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 01/09/1997 | WO1997000956A1 Hypoxia-responsive adhesion molecules, specific antibodies, and their uses |
| 01/09/1997 | WO1997000954A1 C-cam expression constructs and their application in cancer therapy |
| 01/09/1997 | WO1997000953A1 Aortic preferentially-expressed gene apeg-1 and uses thereof |
| 01/09/1997 | WO1997000952A2 A human edg-2 receptor homolog |
| 01/09/1997 | WO1997000950A1 New immunoregulatory protein lst-1 |
| 01/09/1997 | WO1997000946A1 Immortalized epithelial tumor cell |
| 01/09/1997 | WO1997000894A1 Compounds with growth hormone releasing properties |
| 01/09/1997 | WO1997000892A2 Depigmenting activity of agouti signal protein and peptides thereof |
| 01/09/1997 | WO1997000891A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | WO1997000890A1 Peptide that inhibits blood triglyceride level rise and blood triglyceride level rise inhibitor containing said peptide as active ingredient |
| 01/09/1997 | WO1997000889A1 Peptides binding to low-density lipoproteins |
| 01/09/1997 | WO1997000886A1 Obesity protein intermediates and their preparation and use |
| 01/09/1997 | WO1997000855A1 Herpes ribonucleotide reductase inhibitors |
| 01/09/1997 | WO1997000698A1 Inhibition of hepatitis b replication |
| 01/09/1997 | WO1997000695A1 Haemopoietic growth factor antagonists and uses therefor |
| 01/09/1997 | WO1997000694A1 A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 01/09/1997 | WO1997000693A1 Novel formulation for peptide release |
| 01/09/1997 | WO1997000692A1 ANALGESIC USE OF N-L-α-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER |
| 01/09/1997 | WO1997000691A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | WO1997000690A1 Interleukin-1 receptor-associated protein kinase and assays |
| 01/09/1997 | WO1997000688A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 01/09/1997 | WO1997000623A1 Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals |
| 01/09/1997 | WO1997000601A2 Polypeptides with interleukin-8 receptor binding |
| 01/09/1997 | WO1996040040A3 Thrombin receptor homolog |
| 01/09/1997 | WO1996039511A3 A c5a-like seven transmembrane receptor |
| 01/09/1997 | WO1996039504A3 Methods for distinguishing metastatic and non-metastatic cancers, polynucleotides and polypeptides for use therein |
| 01/09/1997 | WO1996038556A3 Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer |
| 01/09/1997 | WO1996038165A3 Endoparasiticidal agents |
| 01/09/1997 | WO1996037214A3 Compositions of interleukin and pyrimidine nucleosides |
| 01/09/1997 | WO1996032471A3 Atp-diphosphohydrolases, process of purification thereof and process of producing thereof by recombinant technology |
| 01/09/1997 | WO1996032137A3 Methods of inducing immune tolerance using immunotoxins |
| 01/09/1997 | DE19624695A1 Transmethylierungs-Co-Faktor Trans methylation cofactor |
| 01/09/1997 | CA2226085A1 Aortic preferentially-expressed gene and uses thereof |
| 01/09/1997 | CA2225517A1 Haemopoietic growth factor antagonists and uses therefor |
| 01/09/1997 | CA2225462A1 Analgesic use of n-l-.alpha.-aspartyl-l-phenylalanine 1-methyl ester |
| 01/09/1997 | CA2225460A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 01/09/1997 | CA2225406A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | CA2225401A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | CA2225377A1 Novel tgf-.beta. like cytokine |
| 01/09/1997 | CA2225318A1 Diagnostic test for equine arteritis virus mediated disease |
| 01/09/1997 | CA2224995A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 01/09/1997 | CA2224867A1 Obesity protein intermediates and their preparation and use |
| 01/09/1997 | CA2224799A1 A human edg-2 receptor homolog |
| 01/09/1997 | CA2224797A1 Immortalized epithelial tumor cell |
| 01/09/1997 | CA2224691A1 Depigmenting activity of agouti signal protein and peptides thereof |
| 01/09/1997 | CA2224477A1 Inhibition of hepatitis b replication |
| 01/09/1997 | CA2224434A1 Compounds with growth hormone releasing properties |
| 01/09/1997 | CA2219739A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 01/08/1997 | EP0752426A2 Synthetic calibrators for use in immunoassays, consisting of analytes or parts thereof conjugated to inert carrier molecules |
| 01/08/1997 | EP0752248A1 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 01/08/1997 | EP0752008A1 Dna mutagenesis by random fragmentation and reassembly |
| 01/08/1997 | EP0752005A1 Compacted nucleic acids and their delivery to cells |
| 01/08/1997 | EP0752004A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 01/08/1997 | EP0752003A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 01/08/1997 | EP0752002A1 Inhibition of arterial smooth muscle cell proliferation |
| 01/08/1997 | EP0752000A1 Packaging-deficient lentiviruses |
| 01/08/1997 | EP0751994A1 C-terminally truncated cftr genes and proteins |
| 01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 |
| 01/08/1997 | EP0751961A1 Eating suppressant peptides |
| 01/08/1997 | EP0751959A1 Modified polypeptides with increased biological activity |
| 01/08/1997 | EP0751958A1 Flucose containing proteoglycan or acid glycan and their pharmaceutical use |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751955A1 Super proteins including interferons and interleukins |
| 01/08/1997 | EP0751954A1 Anti-inflammatory composition and method with des-tyr dynorphin and analogues |
| 01/08/1997 | EP0751951A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 01/08/1997 | EP0751949A1 Anti-hepatitis b viral oligonucleotides |
| 01/08/1997 | EP0751788A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
| 01/08/1997 | EP0751785A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 01/08/1997 | EP0751784A1 Thyroxin-binding proteins |
| 01/08/1997 | EP0751783A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives |
| 01/08/1997 | EP0751782A1 Methods for altering fertility |
| 01/08/1997 | EP0751781A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40 |
| 01/08/1997 | EP0751780A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 01/08/1997 | EP0751779A1 Selectively cleavable linkers based on iminodiacetic acid ester bonds |
| 01/08/1997 | EP0751774A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives |
| 01/08/1997 | EP0751769A1 Medical treatment using thyroid hormones |
| 01/08/1997 | EP0751768A1 Anti-viral and anti-cancer agents |